Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cells

Blood

Volumn 118, Issue 11, 2011, Pages 3182-3185

  Suzuki, Yuko ^a   Yasui, Hideki ^a   Brzoska, Tomasz ^a   Mogami, Hideo ^b   Urano, Tetsumei ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LYSINE; PLASMIN; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BINDING SITE; BLOOD CLOT LYSIS; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; FIBRINOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

EID: 80052955742     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-05-353912     Document Type: Article

References (12)

1. Kolev K, Machovich R. Molecular and cellular modulation of fibrinolysis. Thromb Haemost. 2003;89(4):610-621. (Pubitemid 36456958)
2. Lacroix R, Sabatier F, Mialhe A, et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood. 2007;110(7):2432-2439. (Pubitemid 47523164)
3. Rijken DC, Lijnen HR. New insights into the molecular mechanisms of the fibrinolytic system. J Thromb Haemost. 2009;7(1):4-13.
4. Suzuki Y, Mogami H, Ihara H, Urano T. Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells. Blood. 2009;113(2):470-478.
5. Urano T, Strandberg L, Johansson LB, Ny T. A substrate-like form of plasminogen-activator-inhibitor type 1: conversions between different forms by sodium dodecyl sulphate. Eur J Biochem. 1992;209(3):985-992.
6. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A. 1983;80(12):3734-3737. (Pubitemid 13063134)
7. Emeis JJ, Edgell CJ. Fibrinolytic properties of a human endothelial hybrid cell line (Ea.hy 926). Blood. 1988;71(6):1669-1675.
8. 2+-dependent activation of phospholipase C in insulin-secreting cells. J Biol Chem. 2006;281(39):28499-28507.
9. Das R, Burke T, Plow EF. Histone H2B as a functionally important plasminogen receptor on macrophages. Blood. 2007;110(10):3763-3772. (Pubitemid 350159647)
10. Suenson E, Lutzen O, Thorsen S. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. Eur J Biochem. 1984;140(3):513-522. (Pubitemid 14146534)
11. Fleury V, Loyau S, Lijnen HR, Nieuwenhuizen W, Angles-Cano E. Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface. Eur J Biochem. 1993;216(2):549-556. (Pubitemid 23276302)
12. Sakharov DV, Nagelkerke JF, Rijken DC. Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis: study with confocal microscopy. J Biol Chem. 1996;271(4):2133-2138.